CrowdStrike
CRWD
$229.06
+1.46%
CrowdStrike Holdings is a cloud-native cybersecurity company whose Falcon platform delivers unified endpoint, cloud workload, identity, and security operations protection to enterprises, competing in the fast-growing software-infrastructure security market. The Austin-based firm, founded in 2011 and public since 2019, has established itself as a platform consolidator and category leader in endpoint detection and response, using its single-agent architecture and threat-intelligence graph as a competitive moat against legacy point solutions and larger diversified security vendors. The current investor narrative centers on a sharp reacceleration in growth and a visible path to GAAP profitability: revenue grew 25.8% year over year in the July 2026 quarter to $1.47 billion, gross margin held near 74.6%, and net income turned positive at $5.3 million after a string of prior-year losses. That turnaround, combined with heavy AI-driven security demand and a wave of constructive analyst revisions, has driven the stock up roughly 63% over the past year, though a recent 18% one-month pullback has reignited debate over whether the premium valuation is sustainable.…
CRWD
CrowdStrike
$229.06
Related headlines
Investment Opinion: Should I buy CRWD Today?
Rating: Buy, with position sizing discipline. The core thesis is that CrowdStrike is a category-leading security platform whose revenue has reaccelerated to 25.8% year-over-year growth ($1.471 billion in the July 2026 quarter) while GAAP net income inflected from -$77.7 million to +$5.3 million, and the 41-Buy/11-Hold/1-Sell consensus with a $249.68 average target implies 15.1% upside from $216.90. The recommendation is anchored on the analyst consensus 'buy' rating (recommendation mean 1.66) and the fact that Deutsche Bank upgraded to Buy on November 2, 2026, with Mizuho, KeyBanc, Citigroup, Wells Fargo, BMO, BTIG, and Needham reiterating Outperform into the recent pullback rather than capitulating.
Supporting evidence is strong on growth and cash generation but stretched on valuation. Revenue rose sequentially from $1.305 billion (January) to $1.386 billion (April) to $1.471 billion (July), with subscription revenue of $1.400 billion of the total, and gross margin held at 74.6% ($1.097 billion gross profit). Free cash flow is $1.573 billion trailing twelve months, with $405.9 million generated in the July quarter against $124.4 million of capex, and the balance sheet carries just 0.185 debt-to-equity, a 1.77 current ratio, and $5.18 billion of cash. The offset is the price: 23.2x sales, 40.4x EV/sales, 586.8x EV/EBITDA, and 134.7x forward earnings versus high-growth security peers typically at high-single-digit to low-teens PS, and operating margin remains -2.3% with $376.9 million of quarterly stock-based compensation dwarfing $5.3 million of net income.
The biggest risks that could invalidate the thesis are (1) failure of operating leverage to materialize — sales and marketing of $510 million plus R&D of $444 million still consume 65% of revenue, so the 134.7x forward PE rests on a margin bridge that has not yet been crossed; (2) multiple compression if growth decelerates below 20%, which would pull the $249.68 average target toward the $132.00 low (about -39%); and (3) competitive share loss to platform consolidators such as Palo Alto Networks and Fortinet. This Buy would upgrade to a higher-conviction stance if operating margin turns sustainably positive and forward PE compresses below 100x on rising estimates, and would downgrade to Hold if revenue growth falls below 20% or if the stock breaks decisively below the ~$200 support tested in August and September. On valuation, the stock is fairly valued to modestly rich relative to peers but near the low end of its own historical PS band (23.2x versus a 39x-162x multi-year range), so the verdict is premium-priced but no longer priced for the extreme optimism of prior cycles.
Sign up to view all
CRWD 12-Month Price Forecast
The forward view is constructive but not complacent: fundamentals are inflecting in the right direction, with 25.8% revenue growth, a swing to positive net income, and $1.573 billion of trailing free cash flow supporting the 41-Buy consensus and $249.68 average target. The constraint is valuation — 23.2x sales and 134.7x forward earnings mean the base case (50% probability, $240-$260) depends on operating margin progressing from -2.3% toward breakeven while growth holds in the low-to-mid 20s, and the bear case (25%, $132-$180) is a realistic -39% outcome if growth falls below 20%. The 18.3% one-month decline with a -13.3 relative-strength reading looks like a mean-reversion pullback within a 62.9% one-year uptrend rather than a broken thesis, and the stock at 65.5% of its 52-week range still has room to the $286.99 high. I would upgrade to high confidence if the next quarter shows positive operating margin alongside 25%+ growth, and downgrade to neutral if growth slips below 20% or the stock breaks the ~$200 support on volume.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CrowdStrike's 12-month outlook, with a consensus price target around $249.68 and implied upside of +9.0% versus the current price.
Average Target
$249.68
53 analysts
Implied Upside
+9.0%
vs. current price
Analyst Count
53
covering this stock
Price Range
$132 - $325
Analyst target range
Coverage is deep and overwhelmingly constructive, with 50 analysts publishing ratings split 41 Buy, 11 Hold, and 1 Sell, yielding a consensus recommendation of "buy" and a recommendation mean of 1.66 (where 1.0 is a strong buy). The average target price of $249.68 implies roughly 15.1% upside from the current $216.90, and the consensus clearly leans bullish given that more than 80% of ratings are Buy. Recent institutional activity reinforces the positive tilt, with Deutsche Bank upgrading to Buy from Hold on November 2, 2026, and a steady stream of reiterations at Outperform or Overweight from Mizuho, KeyBanc, Citigroup, Wells Fargo, BMO, BTIG, and Needham through October, indicating analysts are holding or raising conviction into the recent pullback rather than capitulating. The target range is wide, spanning $132.00 at the low to $325.00 at the high, a spread of nearly 150% of the current price that signals meaningful disagreement about the growth and margin trajectory. The $325 high target likely assumes sustained 25%+ growth, continued margin expansion toward GAAP profitability, and multiple expansion as the AI-security narrative strengthens, while the $132 low target appears to price in a growth deceleration, competitive pressure from platform rivals, and multiple compression toward peer levels. The wide dispersion, combined with the stock's 1.15 beta and -37.2% maximum drawdown, means investors should treat the consensus target as a directional signal rather than a precise price objective, and position sizing should account for the genuine two-sided uncertainty in the name.
Bulls vs Bears: CRWD Investment Factors
The bull case currently holds the stronger evidence: revenue reaccelerated to 25.8% growth, net income swung from -$77.7 million to +$5.3 million year over year, free cash flow is $1.573 billion trailing twelve months, and 41 of 50 analysts rate the stock Buy with a $249.68 average target implying 15.1% upside. The bear case rests not on deteriorating fundamentals but on price: 23.2x sales, 134.7x forward earnings, and 586.8x EV/EBITDA leave no margin for error, and the 18.3% one-month decline with -13.3 relative strength shows how violently the market reprices when sentiment shifts. The single most important tension is whether CrowdStrike can convert its 74.6% gross margin into sustainably positive operating margin — currently -2.3% — because that is the bridge between the 134.7x forward PE and a valuation the market can defend. If operating leverage materializes on schedule, the premium is justified by growth; if sales and marketing spend keeps pace with revenue, the multiple compresses toward peer levels and the $132 low target becomes relevant.
Bullish
- Revenue reaccelerating to 25.8% YoY: July 2026 quarterly revenue of $1.471 billion grew 25.8% year over year and rose sequentially from $1.386 billion in April and $1.305 billion in January, showing acceleration rather than deceleration. Subscription revenue of $1.400 billion out of the total confirms a durable recurring model with only $70.6 million from lumpy professional services.
- Decisive swing to GAAP profitability: Net income turned positive at $5.3 million in the July 2026 quarter versus a $77.7 million loss a year earlier, and the prior three quarters printed $27.8 million, $59.4 million, and -$34.0 million. Net margin improved from -6.6% to +0.4% year over year, marking a genuine inflection rather than a one-off.
- Robust free cash flow generation: Trailing twelve-month free cash flow stands at $1.573 billion, with $405.9 million generated in the July quarter and $493.3 million in April. Operating cash flow of $530.3 million comfortably covered $124.4 million of capex, demonstrating the business funds its own growth.
- Analyst consensus firmly bullish: Of 50 analysts, 41 rate Buy versus 11 Hold and 1 Sell, producing a recommendation mean of 1.66 and a consensus 'buy'. The average target of $249.68 implies 15.1% upside from $216.90, and Deutsche Bank upgraded to Buy on November 2, 2026, with Mizuho, KeyBanc, Citigroup, and Wells Fargo reiterating Outperform into the pullback.
Bearish
- Extreme valuation multiples leave no cushion: At $216.90 the stock trades at 23.2x price-to-sales, 40.4x EV/sales, 586.8x EV/EBITDA, and 134.7x forward earnings, versus high-growth security peers typically at high-single-digit to low-teens PS. The 25.2x price-to-book and 69.1x price-to-cash-flow reinforce that any growth stumble would trigger severe multiple compression.
- Operating margin still negative at -2.3%: Despite positive net income, operating income was -$33.2 million in the July quarter, with sales and marketing of $510 million and R&D of $444 million consuming 65% of revenue. The gap between 74.6% gross margin and negative operating margin shows GAAP profitability depends on interest income ($43.9 million) rather than core operations.
- GAAP profit is thin versus stock compensation: Stock-based compensation of $376.9 million in the quarter dwarfs the $5.3 million of net income, meaning reported profitability is largely an accounting artifact of non-cash charges. Trailing ROE of -3.7% and ROA of -0.8% remain negative, and FCF quality depends heavily on adding back SBC.
- Sharp momentum breakdown with high volatility: The stock is down 18.3% over the past month versus a 5.0% decline for SPY, a relative-strength reading of -13.3, and fell from $241.00 on November 4 to $216.90 on November 6 on elevated volume of 11.0 million shares. A beta of 1.15 and maximum drawdown of -37.2% mean drawdowns of this magnitude are a recurring feature, not an anomaly.
CRWD Technical Analysis
CrowdStrike is in a powerful, sustained uptrend that has carried the stock 62.9% higher over the past year and 91.3% year to date, massively outperforming the S&P 500's 9.6% and 7.8% respective gains. At $216.90, the stock sits at roughly 65.5% of its 52-week range of $85.68 to $286.99, meaning it has surrendered a meaningful portion of its highs but remains far above its base. That positioning reflects a stock in a strong primary uptrend that is currently digesting a sharp intermediate correction rather than a broken trend. Recent momentum is clearly negative and diverging from the longer-term picture: the stock is down 18.3% over the past month versus a 5.0% decline for SPY, producing a relative-strength reading of -13.3, while the three-month change is a modest +1.2% (a +6.1% relative-strength edge). This divergence between a strong 1-year trend and a weak 1-month trend signals a mean-reversion pullback within an uptrend, and the most recent sessions confirm the pressure, with the stock falling from $241.00 on November 4 to $217.20 on November 5 and $216.90 on November 6 on elevated volume of roughly 11.0 million shares. Key technical support sits at the 52-week low of $85.68, with nearer-term psychological support around the $200 round number that was tested repeatedly in August and September; resistance is defined by the 52-week high of $286.99, and a breakout above that level would confirm trend resumption and likely trigger momentum buying. A beta of 1.15 means the stock is about 15% more volatile than the market, which, combined with a maximum drawdown of -37.2%, argues for disciplined position sizing and stop placement given the current 18% pullback.
Beta
1.15
1.15x market volatility
Max Drawdown
-37.2%
Largest decline past year
52-Week Range
$86-$287
Price range past year
Annual Return
+64.6%
Cumulative gain past year
| Period | CRWD Return | S&P 500 |
|---|---|---|
| 1m | -12.9% | -2.4% |
| 3m | +1.6% | -2.3% |
| 6m | +54.2% | +2.8% |
| 1y | +64.6% | +11.3% |
| ytd | +102.0% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRWD Fundamental Analysis
Revenue is growing robustly and, importantly, reaccelerating: the July 2026 quarter delivered $1.471 billion in revenue, up 25.8% year over year, versus $1.386 billion in the April 2026 quarter and $1.305 billion in the January 2026 quarter, extending a steady sequential climb from $1.169 billion in the year-ago July quarter. The subscription and circulation segment generated $1.400 billion of the total, with professional services contributing just $70.6 million, confirming that the recurring subscription model is the growth engine and that the business is not dependent on lumpy services revenue. This trajectory, with quarterly revenue up roughly 26% year over year on a $5.9 billion-plus annualized run rate, supports the thesis that CrowdStrike is taking share in a consolidating security market rather than merely riding category growth. Profitability has inflected decisively: net income was $5.3 million in the July 2026 quarter versus a loss of $77.7 million in the year-ago period, and the prior three quarters printed $27.8 million, $59.4 million, and a loss of $34.0 million, showing a clear swing toward positive earnings. Gross margin has been remarkably stable in the 73.5% to 76.1% band, with the latest quarter at 74.6% and gross profit of $1.097 billion, while operating margin remains slightly negative at -2.3% as heavy sales and marketing ($510 million) and R&D ($444 million) investment continue to weigh on the bottom line. The gap between gross and operating profitability reflects deliberate growth spending rather than structural weakness, and the improving net margin trend from -6.6% a year ago to +0.4% today is the key metric to watch. The balance sheet is a source of strength: debt-to-equity is just 0.185, the current ratio is 1.77, and cash stood at $5.18 billion at quarter-end, giving the company ample liquidity. Free cash flow is robust at $1.573 billion trailing twelve months, with $405.9 million generated in the July quarter alone and $493.3 million in the April quarter, and operating cash flow of $530.3 million in the latest quarter comfortably funds capital expenditures of $124.4 million. However, stock-based compensation of $376.9 million in the quarter is large relative to the $5.3 million of net income, meaning GAAP profitability is thin and FCF quality depends on adjusting for SBC; ROE of -3.7% and ROA of -0.8% remain negative on a trailing basis, reflecting the recent transition period.
Quarterly Revenue
$1.5B
2026-07
Revenue YoY Growth
+25.8%
YoY Comparison
Gross Margin
74.6%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRWD Overvalued?
Because trailing net income is effectively zero (EPS of -$0.0015), the trailing PE of -689.7x is meaningless, so the appropriate primary metric is the price-to-sales ratio of 23.2x, supplemented by the forward PE of 134.7x, which is the market's real earnings-based yardstick. The enormous gap between the negative trailing PE and the 134.7x forward PE implies the market expects a dramatic earnings inflection, consistent with consensus EPS of $2.935 for the coming year versus near-zero trailing EPS. On an EV/Sales basis the stock trades at 40.4x and EV/EBITDA at 586.8x, both extreme multiples that price in years of high growth and margin expansion. Against a software-infrastructure peer set where high-growth security names typically command PS multiples in the high single digits to low teens, CrowdStrike's 23.2x PS represents a substantial premium, likely 50-100% above the group, which is justified only by its 25.8% growth rate, 74.7% gross margin, and platform-leadership position. The 25.2x price-to-book and 69.1x price-to-cash-flow ratios reinforce that this is a premium-multiple asset with little valuation cushion. Historically, CrowdStrike's PS ratio has ranged from roughly 39x to 162x over the past several years, and the current 23.2x sits near the low end of that band, a notable de-rating from the 2021-era peak of 161.7x and even below the 2023-2024 levels in the 50-90x range. That compression reflects both the maturation of the business and the recent price pullback, and while the absolute multiple remains rich, its position near the bottom of the historical range suggests the market is no longer pricing in the extreme optimism of prior cycles, leaving room for multiple stabilization if growth and profitability hold.
PE
-689.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 305x~1135x
vs. Industry Avg
26.1x
Industry PE ~26.1x*
EV/EBITDA
586.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the disconnect between headline profitability and core economics. Operating income was -$33.2 million in the July 2026 quarter despite $1.471 billion of revenue, because sales and marketing ($510 million) plus R&D ($444 million) consumed 65% of the top line, and the $5.3 million of net income was effectively manufactured by $43.9 million of interest income on the $5.18 billion cash pile. Stock-based compensation of $376.9 million in the quarter is 71 times net income, so GAAP profitability is thin and highly sensitive to SBC policy and dilution — diluted shares rose to 1.038 billion from 999.6 million a year earlier. Revenue concentration in subscriptions ($1.400 billion of $1.471 billion) is a strength for durability but means any renewal slowdown or seat contraction among large enterprise customers would hit the growth engine directly, and trailing ROE of -3.7% and ROA of -0.8% confirm the business has not yet proven it can earn returns on its invested capital. Market and competitive risks are dominated by valuation compression. At 23.2x sales, 40.4x EV/sales, and 134.7x forward earnings, CrowdStrike trades at a 50-100% premium to high-growth security peers in the high-single-digit to low-teens PS range, so a rotation away from premium software multiples would hit the stock disproportionately — the 18.3% one-month decline versus SPY's 5.0% drop, a -13.3 relative-strength reading, illustrates exactly this dynamic. Competition from platform consolidators such as Palo Alto Networks and Fortinet, both cited in recent coverage as gaining security-platform demand, threatens CrowdStrike's share gains, while macro sensitivity is amplified by a 1.15 beta and by the September FOMC meeting being flagged as a tone-setter for tech, with AI regulation concerns dividing chipmakers from cybersecurity names. The worst-case scenario is a growth deceleration below 20% coinciding with multiple compression toward peer levels: revenue misses would force analysts to cut the $249.68 average target toward the $132.00 low, and the stock could retrace toward its 52-week low of $85.68, a decline of roughly 60% from $216.90. A more realistic adverse path — growth slowing to the high teens while the forward PE compresses from 134.7x toward 80-90x — would put the shares near the $132 low target, about -39% from the current price, consistent with the stock's demonstrated -37.2% maximum drawdown. Investors should size positions for a genuine 35-40% downside scenario, not a mild correction.
FAQ
The most severe risk is valuation compression: at 23.2x sales and 134.7x forward earnings, a de-rating toward peer multiples could take the stock toward the $132.00 low target, about -39% from $216.90. Second is the margin bridge failing — operating income was -$33.2 million in the July 2026 quarter because sales and marketing ($510 million) plus R&D ($444 million) consumed 65% of revenue, and the $5.3 million of net income was effectively carried by $43.9 million of interest income. Third is competitive share loss to platform consolidators such as Palo Alto Networks and Fortinet, which recent coverage flags as gaining security-platform demand and would directly threaten the 25.8% growth engine. Fourth is momentum and macro sensitivity: an 18.3% one-month decline versus SPY's 5.0% drop, a -13.3 relative-strength reading, a 1.15 beta, and a -37.2% maximum drawdown mean the stock amplifies risk-off rotations, with the 52-week low of $85.68 representing a roughly 60% worst-case retrace.
The 12-month view is split into a 50% base case of $240-$260, a 25% bull case of $286.99-$325.00, and a 25% bear case of $132.00-$180.00. The base case is most likely and assumes growth moderates only modestly from 25.8% into the low-to-mid 20s, gross margin holds near 74.6%, operating margin grinds toward breakeven, and forward EPS tracks the $2.935 consensus — producing roughly 11%-20% upside and converging on the $249.68 average target. The bull case requires growth at or above 25% with operating margin turning sustainably positive, re-rating the stock toward the 52-week high of $286.99 and the $325.00 high target. The bear case assumes growth falls below 20%, forcing target cuts toward the $132.00 low and compressing the forward PE from 134.7x toward 80-90x.
The trailing PE of -689.7x is meaningless given near-zero trailing EPS of -$0.0015, so the operative metrics are 23.2x price-to-sales, 40.4x EV/sales, 586.8x EV/EBITDA, and 134.7x forward earnings on the $2.935 consensus EPS. Against high-growth security peers typically at high-single-digit to low-teens PS, CrowdStrike commands a 50-100% premium that is only defensible on its 25.8% growth rate and 74.6% gross margin. The important nuance is history: the stock's PS ratio has ranged from roughly 39x to 162x over recent years, so 23.2x sits near the low end of its own band, well below the 2021-era peak. The market is thus pricing in continued high growth and a margin bridge from -2.3% operating margin toward breakeven, but no longer the extreme optimism of prior cycles — premium-priced, yet not priced for perfection.
From a risk/reward standpoint the setup is favorable but not cheap: the $249.68 average analyst target implies 15.1% upside from $216.90, and 41 of 50 analysts rate the stock Buy with a recommendation mean of 1.66. The fundamental case is real — revenue grew 25.8% year over year to $1.471 billion, net income turned positive at $5.3 million versus a $77.7 million loss, and trailing free cash flow is $1.573 billion against debt-to-equity of just 0.185. The downside is equally concrete: the $132.00 low target implies roughly 39% downside, and the stock's -37.2% maximum drawdown shows that magnitude of loss is a realistic, recurring outcome rather than a tail event. It is therefore a good buy primarily for growth investors with a multi-year horizon who can tolerate a 35-40% drawdown and size positions accordingly, and a poor fit for capital-preservation or income mandates given the 0% dividend yield and 134.7x forward earnings.
The profile favors long-term holding over short-term trading. The company is in a high-growth stage with a $5.9 billion-plus annualized revenue run rate, 25.8% year-over-year growth, and a margin inflection still in progress, so the earnings visibility that supports a 134.7x forward multiple only resolves over multiple quarters. Volatility argues against short-term positioning: beta of 1.15, a -37.2% maximum drawdown, and an 18.3% one-month decline with -13.3 relative strength mean entry timing is difficult and drawdowns are frequent. There is no dividend (0% yield, payout ratio 0), so all return must come from price appreciation, which requires patience through multiple compression cycles. A minimum holding period of two to three years is appropriate, long enough to see whether operating margin turns sustainably positive and whether the $2.935 forward EPS estimate is delivered.